Authors:
Kugler, A
Stuhler, G
Walden, P
Zoller, G
Zobywalski, A
Brossart, P
Trefzer, U
Ullrich, S
Muller, CA
Becker, V
Gross, AJ
Hemmerlein, B
Kanz, L
Muller, GA
Ringert, RH
Citation: A. Kugler et al., Regression of human metastatic renal cell carcinoma after vaccination withtumor cell-dendritic cell hybrids, NAT MED, 6(3), 2000, pp. 332-336
Authors:
Trefzer, U
Rietz, N
Chen, YW
Audring, H
Herberth, G
Siegel, P
Reinke, S
Koniger, P
Wu, SG
Ma, J
Liu, YJ
Wang, H
Sterry, W
Cuo, YJ
Citation: U. Trefzer et al., SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions, ARCH DERM R, 292(12), 2000, pp. 583-589
Authors:
Trefzer, U
Weingart, G
Chen, YW
Herberth, G
Adrian, K
Winter, H
Audring, H
Guo, YJ
Sterry, W
Walden, P
Citation: U. Trefzer et al., Hybrid cell vaccination for cancer immune therapy: First clinical trial with metastatic melanoma, INT J CANC, 85(5), 2000, pp. 618-626
Authors:
Becker, J
Brocker, EB
Dummer, R
Enk, A
Garbe, C
Hauschild, A
Hein, R
Kaufmann, R
Krahn, G
Lohmann, F
Luther, H
Mauch, C
Mohr, P
Nashan, D
Neuber, K
Peter, RU
Reinhold, U
Schadendorf, D
Sebastian, G
Soyer, P
Stadler, R
Stolz, W
Tilgen, W
Trefzer, U
Tronnier, M
Ulrich, J
Volkenandt, M
Citation: J. Becker et al., Current position of the Working Group on Dermatological Oncology on high-dose therapy with interferon alpha 2b, HAUTARZT, 50(6), 1999, pp. 395-397